174 related articles for article (PubMed ID: 11591541)
1. Severe community-acquired pneumonia due to Acinetobacter baumannii.
Chen MZ; Hsueh PR; Lee LN; Yu CJ; Yang PC; Luh KT
Chest; 2001 Oct; 120(4):1072-7. PubMed ID: 11591541
[TBL] [Abstract][Full Text] [Related]
2. Severe community-acquired Acinetobacter baumannii pneumonia: an emerging highly lethal infectious disease in the Asia-Pacific.
Ong CW; Lye DC; Khoo KL; Chua GS; Yeoh SF; Leo YS; Tambyah PA; Chua AC
Respirology; 2009 Nov; 14(8):1200-5. PubMed ID: 19909464
[TBL] [Abstract][Full Text] [Related]
3. Diagnosis of severe community-acquired pneumonia caused by Acinetobacter baumannii through next-generation sequencing: a case report.
Xu A; Zhu H; Gao B; Weng H; Ding Z; Li M; Weng X; He G
BMC Infect Dis; 2020 Jan; 20(1):45. PubMed ID: 31941459
[TBL] [Abstract][Full Text] [Related]
4. Severe Community-acquired Pneumonia Caused by Acinetobacter baumannii Successfully Treated with the Initial Administration of Meropenem Based on the Sputum Gram Staining Findings.
Iwasawa Y; Hosokawa N; Harada M; Hayano S; Shimizu A; Suzuki D; Nakashima K; Yaegashi M
Intern Med; 2019 Jan; 58(2):301-305. PubMed ID: 30210104
[TBL] [Abstract][Full Text] [Related]
5. Community-acquired Acinetobacter baumannii pneumonia.
Bachoumas K; Lebert C; Lacherade JC; Reignier J
Med Mal Infect; 2015 Aug; 45(8):337-9. PubMed ID: 26141128
[No Abstract] [Full Text] [Related]
6. Community-acquired bloodstream infections caused by Acinetobacter baumannii: A matched case-control study.
Chen CT; Wang YC; Kuo SC; Shih FH; Chen TL; How CK; Yang YS; Lee YT
J Microbiol Immunol Infect; 2018 Oct; 51(5):629-635. PubMed ID: 28701266
[TBL] [Abstract][Full Text] [Related]
7. Predictors of mortality in Acinetobacter baumannii bacteremia.
Chen HP; Chen TL; Lai CH; Fung CP; Wong WW; Yu KW; Liu CY
J Microbiol Immunol Infect; 2005 Apr; 38(2):127-36. PubMed ID: 15843858
[TBL] [Abstract][Full Text] [Related]
8. Community-acquired acinetobacter pneumonia.
Rudin ML; Michael JR; Huxley EJ
Am J Med; 1979 Jul; 67(1):39-43. PubMed ID: 463916
[TBL] [Abstract][Full Text] [Related]
9. [Community-acquired Acinetobacter baumannii pneumonia].
Salas Coronas J; Cabezas Fernández T; Alvarez-Ossorio García de Soria R; Díez García F
Rev Clin Esp; 2003 Jun; 203(6):284-6. PubMed ID: 12783714
[TBL] [Abstract][Full Text] [Related]
10. Comparison of the clinical efficacy between tigecycline plus extended-infusion imipenem and sulbactam plus imipenem against ventilator-associated pneumonia with pneumonic extensively drug-resistant Acinetobacter baumannii bacteremia, and correlation of clinical efficacy with in vitro synergy tests.
Jean SS; Hsieh TC; Hsu CW; Lee WS; Bai KJ; Lam C
J Microbiol Immunol Infect; 2016 Dec; 49(6):924-933. PubMed ID: 26341302
[TBL] [Abstract][Full Text] [Related]
11. Fulminant community-acquired pneumonia probably caused by Acinetobacter lwoffii.
Toyoshima M; Chida K; Suda T
Respirology; 2010 Jul; 15(5):867-8. PubMed ID: 20546186
[TBL] [Abstract][Full Text] [Related]
12. Acinetobacter baumannii ventilator-associated pneumonia: epidemiology, clinical characteristics, and prognosis factors.
Chaari A; Mnif B; Bahloul M; Mahjoubi F; Chtara K; Turki O; Gharbi N; Chelly H; Hammami A; Bouaziz M
Int J Infect Dis; 2013 Dec; 17(12):e1225-8. PubMed ID: 24094525
[TBL] [Abstract][Full Text] [Related]
13. Antibiotic strategies and clinical outcomes in critically ill patients with pneumonia caused by carbapenem-resistant Acinetobacter baumannii.
Liang CA; Lin YC; Lu PL; Chen HC; Chang HL; Sheu CC
Clin Microbiol Infect; 2018 Aug; 24(8):908.e1-908.e7. PubMed ID: 29108947
[TBL] [Abstract][Full Text] [Related]
14. A 16-year prospective study of community-onset bacteremic Acinetobacter pneumonia: low mortality with appropriate initial empirical antibiotic protocols.
Davis JS; McMillan M; Swaminathan A; Kelly JA; Piera KE; Baird RW; Currie BJ; Anstey NM
Chest; 2014 Oct; 146(4):1038-1045. PubMed ID: 24901292
[TBL] [Abstract][Full Text] [Related]
15. Fulminant community-acquired Acinetobacter baumannii pneumonia as a distinct clinical syndrome.
Leung WS; Chu CM; Tsang KY; Lo FH; Lo KF; Ho PL
Chest; 2006 Jan; 129(1):102-9. PubMed ID: 16424419
[TBL] [Abstract][Full Text] [Related]
16. Treatment outcomes of patients with non-bacteremic pneumonia caused by extensively drug-resistant Acinetobacter calcoaceticus-Acinetobacter baumannii complex isolates: Is there any benefit of adding tigecycline to aerosolized colistimethate sodium?
Jean SS; Hsieh TC; Lee WS; Hsueh PR; Hsu CW; Lam C
Medicine (Baltimore); 2018 Sep; 97(39):e12278. PubMed ID: 30278498
[TBL] [Abstract][Full Text] [Related]
17. A case-control study of community-acquired Acinetobacter baumannii pneumonia and melioidosis pneumonia in northeast Thailand: an emerging fatal disease with unique clinical features.
Patamatamkul S; Klungboonkrong V; Praisarnti P; Jirakiat K
Diagn Microbiol Infect Dis; 2017 Jan; 87(1):79-86. PubMed ID: 27789057
[TBL] [Abstract][Full Text] [Related]
18. Sputum bacteriology and antibiotic sensitivity patterns of community-acquired pneumonia in hospitalized adult patients in Nigeria: a 5-year multicentre retrospective study.
Iroezindu MO; Chima EI; Isiguzo GC; Mbata GC; Onyedum CC; Onyedibe KI; Okoli LE
Scand J Infect Dis; 2014 Dec; 46(12):875-87. PubMed ID: 25288384
[TBL] [Abstract][Full Text] [Related]
19. Community-acquired bacteraemic Acinetobacter pneumonia with survival.
Achar KN; Johny M; Achar MN; Menon NK
Postgrad Med J; 1993 Dec; 69(818):934-7. PubMed ID: 8121870
[TBL] [Abstract][Full Text] [Related]
20. Clinical experience of tigecycline treatment in infections caused by extensively drug-resistant Acinetobacter spp.
Moon SY; Peck KR; Chang HH; Kim SW; Heo ST; Son JS; Ryu SY; Moon C; Jung SI; Shin SY; Lee JA; Joung MK; Chung DR; Kang CI; Song JH
Microb Drug Resist; 2012 Dec; 18(6):562-6. PubMed ID: 22775562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
